SGAM
Smith Group Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.6M | Buy |
46,255
+612
| +1% | +$272K | 1.35% | 34 |
|
|
2025
Q1 | $22.1M | Buy |
45,643
+2,010
| +5% | +$974K | 1.66% | 31 |
|
|
2024
Q4 | $17.6M | Sell |
43,633
-26
| -0.1% | -$10.5K | 1.3% | 33 |
|
|
2024
Q3 | $20.3M | Buy |
43,659
+749
| +2% | +$348K | 1.68% | 30 |
|
|
2024
Q2 | $20.1M | Buy |
42,910
+1,872
| +5% | +$877K | 1.78% | 28 |
|
|
2024
Q1 | $17.2M | Buy |
41,038
+4,454
| +12% | +$1.86M | 0.98% | 37 |
|
|
2023
Q4 | $14.9M | Buy |
+36,584
| New | +$14.9M | 0.87% | 47 |
|
|
2022
Q1 | $4.97M | Buy |
+19,060
| New | +$4.97M | 0.26% | 80 |
|
|
2021
Q1 | – | Sell |
-29,220
| Closed | -$6.91M | – | 343 |
|
|
2020
Q4 | $6.91M | Sell |
29,220
-15,200
| -34% | -$3.59M | 0.4% | 54 |
|
|
2020
Q3 | $12.1M | Sell |
44,420
-110
| -0.2% | -$29.9K | 0.63% | 44 |
|
|
2020
Q2 | $12.9M | Buy |
+44,530
| New | +$12.9M | 0.71% | 41 |
|
|
2018
Q1 | – | Sell |
-65,010
| Closed | -$9.74M | – | 462 |
|
|
2017
Q4 | $9.74M | Sell |
65,010
-65,790
| -50% | -$9.86M | 0.31% | 76 |
|
|
2017
Q3 | $19.9M | Sell |
130,800
-60,280
| -32% | -$9.17M | 0.66% | 57 |
|
|
2017
Q2 | $24.6M | Buy |
+191,080
| New | +$24.6M | 0.76% | 55 |
|